Abstract
The critical role of horses in the development of transportation systems and the economies of nations has historically maintained equine infectious disease research as a high priority in veterinary medicine. This research has produced a number of pioneering studies in the field of retrovirology that have not only led to improved control of retrovirus-induced disease in the general horse population, but also provided an important animal model for studying the epidemiology of a retrovirus infection, for examining the mechanisms of viral persistence and pathogenesis, and for evaluating various strategies for prevention or therapy of viral replication and disease. The purpose of this review is to summarize the current state of equine retrovirology and to identify significant questions that should be a priority for future research efforts.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alexandersen, S., and Carpenter, S., 1991, Characterization of variable regions in the envelope and S3 open reading frame of equine infectious anemia virus, J. Virol. 62:4255.
Allan, J. S., Coligan, J. E., Barin, F., Mclane, M. F.; Sodroski, J. G., Rosen, C. A., Haseltine, W. A., Lee, T. H., and Essex, M., 1985, Major glycoprotein antigens that induce antibodies in AIDS are encoded by HTLV-III, Science 228:1091.
Air, G. M., and Laver, W. G., 1986, The molecular basis of antigenic variation in influenza virus, in: Advances in Virus Research, Vol. 31, pp. 53–102, Academic Press, New York.
Anderson, M. G., and Clements, J. E., 1991, Comparison of the transcriptional activity of the long terminal repeats of simian immunodeficiency viruses SIVmac25i and SIVmac239 in T-cell lines and macrophage cell lines, J. Virol. 65:51.
Andreassen, H., Bohr, H., Brunak, S., Bugge, T., Cotterill, R. M. J., Jacobsen, C., Kusk, P., Lautrup, B., Petersen, S. B., Saermark, T., and Ulrich, K., 1990, Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods, J. Acq. Immun. Dej. Syn. 3:615.
Archer, B. G., Crawford, T. B., McGuire, T. C., and Frazier, M. E., 1977, RNA-dependent DNA polymerase associated with equine infectious anemia virus, J. Virol. 22:16.
Argos, P., 1989, A possible homology between immunodeficiency virus p24 core protein and picornaviral VP2 coat protein: Prediction of HIV antigenic sites, EMBO J. 8:779.
Arthur, L. O., Bess, J. W., Waters, D. J., Pyle, S. W., Kelliher, J. C., Nara, P. L., Krohn, K., Robey, W. G., Langlois, A. J., Gallo, R. C., and Fischenger, P. J., 1989, Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120, J. Virol. 63:5046.
Arya, S. K., 1988, Human and simian immunodeficiency retroviruses: Activation and differential transactivation of gene expression, AIDS Res. Hum. Retroviruses 4:175.
Arya, S. K., and Gallo, R. C., 1986. Three novel genes of the human T-lymphotropic virus type-Ill: Immune reactivity of their products with sera from acquired immune deficiency syndrome. Proc. Natl. Acad. Sci. USA 83:2209.
Arya, S. K., Gallo, R. C., Hahn, B. H., Shaw, G. W., Popovic, M., Salahuddin, S. Z., and Staal, F. W., 1984, Homology of the genome of AIDS-associated virus with genomes of human T-cell leukemia viruses, Science 225:927.
Balachandran, R., Thampatty, P., Enrico, A., Rinaldo, C., and Gupta, P., 1991, Human immunodeficiency virus isolates from asymptomatic homosexual men and from AIDS patients have distinct biologic and genetic properties, Virology 180:229.
Balfe, P., Simmonds, P., Ludlam, C. A., Bishop, J. O., and Brown, A. J. L., 1990. Concurrent evolution of human immunodeficiency virus type 1 in patients infected from the same source: Rate of sequence change and low frequency of inactivating mutations. J. Virol. 64:6221.
Ball, J. M., 1990, Synthetic peptide analyses of the surface glycoproteins of equine infectious anemia virus, Ph.D. dissertation, Louisiana State University.
Ball, J. M., Rao, R. S. V., Robey, W. G., Issel, C. J., and Montelaro, R. C., 1988a, Lentivirus antigen purification and characterization: Isolation of equine infectious anemia virus gag and env proteins in one step by reverse phase HPLC and application to human immunodeficiency virus glycoproteins, J. Virol. Methods 19:265.
Ball, J. M., Payne, S. L., Issel, C. J., and Montelaro, R. C., 1988b, EIAV genomic organization: Further characterization by sequencing of cDNA and purified glycoproteins, Virology 165:601.
Ball, J. M., Rushlow, K. E., Issel, C. J., and Montelaro, R. C., 1992, Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide methodologies, J. Virol. 66:732.
Banks, K. L., 1975, Monocyte activation in horses persistently infected with equine infectious anemia virus, Infect. Immun. 12:1219.
Banks, K. L., and Henson, J. B., 1973, Quantitation of immunoglobulin-bearing lymphocytes and lymphocyte responses to mitogens in horses persistently infected by equine infectious anemia virus, Infect. Immun. 8:679.
Bass, B. L., Weintraub, H., Cattaneo, R., and Billeter, M. A., 1989, Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA, Cell 56:331.
Benko, D. M., Schwartz, S., Pavlakis, G. N., and Felber, B. K., 1990, A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins, J. Virol. 64:2505.
Beisel, C. E., Edwards, J. F., Dunn, L. L., and Rice, N. R., 1993, Analysis of multiple mRNAs from pathogenic equine infectious anemia virus (EIAV) in an acutely infected horse reveals a novel protein, Ttm, derived from the carboxy terminus of the EIAV transmembrane protein, J. Virol. 67:832-842.
Benton, C. V., Brown, B. L., Harshman, J. S., and Gilden, R. V., 1981, In vitro host range of equine infectious anemia virus, Intervirology 16:225.
Berkhout, B., Gatignol, A., Rabson, A. B., and Jeang, K. T., 1990, TAR-independent activation of the HIV-1 LTR: Evidence that Tat requires specific regions of the promoter, Cell 62:757.
Berman, P. W., Groopman, J. E., Gregory, T., Clapham, P. R., Weiss, R. A., Ferriani, R., Riddle, L., Shimasaki, C., Lucas, C., Lasky, L. A., and Eichberg, J. W., 1988, Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120, Proc. Natl Acad. Sci. USA 85:5200.
Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champs, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. V., Cobb, E. K., and Eichberg, J. W., 1990, Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160, Nature 345:622.
Borroto-Esoda, K., and Boone, L. R., 1991, Equine infectious anemia virus and human immunodeficiency virus DNA synthesis in vitro: Characterization of the endogenous reverse transcriptase reaction, J. Virol. 65:1952.
Brasseur, R., Cornet, B., Burny, A., Vandenbranden, M., and Ruysschaert, J. M., 1988, Mode of insertion into a lipid membrane of the N-terminal of HIV-1 gp41 peptide segment, AIDS Res. Hum. Retroviruses 4:83.
Braun, M. J., Clements, J. E., and Gonda, M. A., 1987, The visna virus genome: Evidence for a hypervariable site in the env gene and sequence homology among lentivirus envelope proteins, J. Virol. 61:4046.
Burki, F., and Rossmanith, E., 1990, Comparative evaluation of the agar gel immunodiffusion test and two commercial ELISA kits for the serodiagnosis of equine infectious anemia virus, J. Vet. Med. 37:448.
Carlson, J., McGraw, T. P., Keddie, E., Yee, Y. L., Rosenthal, A., Langlois, A. J., Dickover, R., Donovan, R., Luciw, P. A., Jennings, M. B., and Gardner, M. B., 1990, Vaccine protection of rhesus macques against simian immunodeficiency virus infection, AIDS Res. Hum. Retroviruses 6:1239.
Carpenter, S., and Chesebro, B., 1989, Change in host cell tropism associated with in vitro replication of equine infectious anemia virus, J. Virol. 63:2492.
Carpenter, S., Evans, L. H., Sevoian, M., and Chesebro, B., 1987, Role of host immune response in selection of equine infectious anemia virus variants, J. Virol. 61:3783.
Carpenter, S., Alexandersen, S., Long, M. J., Perryman, S., and Chesebro, B., 1991, Identification of a hypervariable region in the long terminal repeat of equine infectious anemia virus, J. Virol. 65:1605.
Carroll, R., and Derse, D., 1993, Translation of equine infectious anemia virus bicistronic tatrev mRNA requires leaky ribosome scanning of the Tat CTG initiation codon, J. Virol. 67:1433-1440.
Carroll, R., Martarano, L., and Derse, D., 1991, Identification of lentivirus Tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat chimeras, J. Virol. 65:3460.
Carvalho, M., and Derse, D., 1991, Mutational analysis of the equine infectious anemia virus Tat-responsive element, J. Virol. 65:3468.
Cease, K. B., and Berzofsky, J. A., 1988, Antigenic structures recognized by T cells: Towards the rational design of an AIDS vaccine, Aids 2:S95.
Charman, H. P., Bladen, S., Gilden, R. V., and Coggins, L., 1976, Equine infectious anemia virus: Evidence favoring classification as a retrovirus. J. Virol. 19:1073.
Cheevers, W. P., and McGuire, T. C., 1985, Equine infectious anemia virus: Immunopathogenesis and persistence. Rev. Infect. Dis. 7:83.
Cheevers, W. P., and McGuire, T. C., 1988, The lentiviruses maedi/visna, caprine arthritisencephalitis, and equine infectious anemia, Adv. Virus Res. 34:189.
Cheevers, W. P., Archer, B. G., and Crawford, T. B., 1977, Characterization of RNA from equine infectious anemia virus. J. Virol. 24:489.
Cheevers, W. P., Roberson, S. M., Brassfield, A. L., Davis, W. C., and Crawford, T. B., 1982a, Isolation of a retrovirus from cultured equine sarcoid tumor cells, Am. J. Vet. Res. 43:804.
Cheevers, W. P., Watson, S. G., and Klevj er-Anderson, P., 1982b, Persistent infection by equine infectious anemia virus: Asymetry of nucleotide sequence reiteration in the integrated provirus of persistently infected cells, Virology 118:246.
Cheevers, W. P., Fatemi-Nainie, S., and Anderson, L. W., 1986, Spontaneous expression of an endogenous retrovirus by the equine sarcoid-derived MC-1 line, Am. J. Vet. Res. 47:50.
Cheng-Mayer, C., Seto, D., Tateno, M., and Levy, J., 1988, Biological features of HIV-1 that correlate with virulence in the host, Science 240:80.
Chong, Y. H., Ball, J. M., Issel, C. J., Montelaro, R. C., and Rushlow, K. E., 1991a, Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus, J. Virol. 65:1013.
Chong, Y.-H., Payne, S. L., Issel, C. J., Montelaro, R. C., and Rushlow, K. E., 1991b, Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus, J. Virol. 65:1007.
Chou, P. Y., and Fassman, G. D., 1978, Prediction of the secondary structure of proteins from their amino acid sequence, Adv. Enzymol. 47:45.
Cianciolo, G. J., Copeland, Y. D., Oroszlan, S., and Snyderman, R., 1985, Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins, Science 230:453.
Clabough, D. L., Gebhard, D., Flaherty, M. T., Whetter, L. E., Perry, S. T., Coggins, L., and Fuller, F. J., 1991, Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus, J. Virol. 65:6242.
Clabough-Sellon, D., Perry, S. T., Coggins, L., and Fuller, F. J., 1992, Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes, J. Virol. 66:5906-5913.
Coggins, L., 1982. Carriers of equine infectious anemia virus. J. Am. Vet. Med. Assoc. 184:279.
Coggins, L., and Norcross, N. L., 1970, Immunodiffusion reaction in equine infectious anemia, Cornell Vet. 60:330.
Coggins, L., Norcross, N. L., and Nusbaum, S. R., 1972a, Diagnosis of equine infectious anemia virus antigen and antibody, E. Eq. Med. Surg. (Suppl. 1):251.
Coggins, L., Norcross, N. L., and Nusbaum, S. R.; 1972b, Diagnosis of equine infectious anemia by immunodiffusion test, Am. J. Vet. Res. 33:11.
Cohen, C., and Parry, A. D., 1986, Alpha-helical coiled-coils—a widespread motif in proteins, Trends Biochem. Sci. 11:245.
Coombs, R. W., Collier, A. C., Allain, J. P., Nikora, B., Leuther, M., Gjerset, G. F., and Corey, L., 1989, Plasma viremia in human immunodeficiency virus infection, N. Engl. J. Med. 321:1626.
Crawford, J. B., Cheevers, W. P., Klevj er-Anderson, P., and McGuire, T. C., 1978, Equine infectious anemia: Virion characteristics, virus cell interactions, and hot responses, in: Persistent Viruses (J. G. Stevens, G. J. Todaro, and C. F. Fox, eds.), Vol. 11, pp. 155–162, Academic Press, New York.
Cunningham, T. P., Montelaro, R. C., and Rushlow, K. E., 1993, Lentivirus envelope sequences and proviral genomes are stabilized in Eschericia coli when cloned in low copy-number plasmid vectors, Gene, in press.
Currey, K. M., Peterlin, B. M., and Maizel, J. V., Jr., 1986, Secondary structure analysis of poliovirus RNA: Correlation of computer-predicted with electron microscopically observed structure, Virology 148:33.
Darlix, J. L., Zuker, M., and Spahr, P. F., 1982, Structure-function relationship of Rous sarcoma virus leader RNA, Nucleic Acids Res. 10:5183.
Davis, J. L., Molineaux, S., and Clements, J. E., 1987, Visna virus exhibits a complex transcriptional pattern: One aspect of gene expression shared with the acquired immunodeficiency syndrome retrovirus, J. Virol. 61:1325.
Delwart, E. R., and Mosialos, G., 1990, Letter to the editor, Retroviral envelope glycoproteins contain a “leucine-zipper”-like repeat, AIDS Res. Hum. Retroviruses 6:703.
Derse, D., Dorn, P. L., Levy, L., Stephens, R. M., Rice, N. R., and Casey, J. W., 1987, Characterization of the equine infectious anemia virus long terminal repeat, J. Virol. 61:743.
Derse, D., Dorn, P. L., DaSilva, L., and Martarano, L., 1989, Structure and expression of the equine infectious anemia virus transcriptional trans-activator (tat), in: Developments in Biological Standardization: Progress in Animal Retroviruses (D. Gaudry and W. Hennessen, eds.), Vol. 72, pp. 39–48, S. Karger, Basel.
Derse, D., Carvalho, M., Carroll, R., and Peterlin, B., 1991, A minimal lentivirus Tat, J. Virol. 65:7012.
Desrosiers, R., Wyand, M., Kodama, T., Ringer, D., Arthur, L., Sehgal, P., Letvin, N., King, N., and Daniel, M., 1989, Vaccine protection against simian immunodeficiency virus infection, Proc. Natl. Acad. Sci. USA 86:6353.
DeVico, A., Montelaro, R. C., Gallo, R. C., and Sarngadharan, M. G., 1991, Purification and partial characterization of equine infectious anemia reverse transcriptase. Virology 185:387.
Dewhurst, S., Embretson, J. E., Anderson, D. C., Mullins, J. I., and Fultz, P. N., 1990, Sequence analysis and acute pathogenicity of molecularly cloned SIV smm-pbj14, Nature 345:636.
Dillon, P. J., Nelbock, P., Perkins, A., and Rosen, C. A., 1990, Functions of the human immunodeficiency virus types 1 and 2 rev protein is dependent on their ability to interact with a structured region present in env gene RNA, J. Virol. 64:4428.
Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, K., Lowe, A. D., Singh, M., and Skinner, M. A., 1990, HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:4145.
Doolittle, R. F., Feng, D. F., Mcclure, M. A., and Johnson, M. S., 1990, Retrovirus evolution and phylogeny, in: Current Topics in Microbiol and Immunology: Retrovirus strategy of replication (R. Swanstrom and P. K. Vogt, eds.), Vol. 157, pp. 1–18, Springer-Verlag, New York.
Dorn, P. L., and Derse, D., 1988, Cis-and trans-acting regulation of gene expression of equine infectious anemia virus, J. Virol. 62:3522.
Dorn, P., DaSilva, L., Martarano, L., and Derse, D., 1990, Equine infectious anemia virus tat: Insights into the structure, function, and evolution of lentivirus trans-activator proteins, J. Virol. 64:1616.
Drumm, M. L., Pope, H. A., Cliff, W. H., Rommens, J. M., Marvin, S. A., Tsui, L. C., Collins, F. S., Frizzell, R. A., and Wilson, J. M., 1990, Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer, Cell 62:1227.
Einfeld, D., and Hunter, E., 1988, Oligomeric structure of a prototype retrovirus glycoprotein, Proc. Natl Acad. Sci. USA 85:8688.
Elder, J., Lerner, D., Hasselkus-Light, C., Fontenot, J., Hunter, E., Luciw, P., Montelaro, R., and Phillips, T., 1992, Distinct subsets of retrovirus encode deoxyuridine triphosphatase, J. Virol. 66:1719.
Engelman, D. M., and Steitz, T. A., 1981, The spontaneous insertion of proteins into and across membranes: The helical hairpin hypothesis, Cell 23:411.
England, J. J., Watson, R. E., and Larson, K. A., 1973, Virus-like particles in an equine sarcoid cell line, Am. J. Vet. Res. 34:1601.
Fan, H., 1990, Influence of the long terminal repeats on retrovirus pathogenicity, in: Seminars in Virology: Recent Advances in Retrovirology (Irvin S. Y. Chen, ed.), Vol. 1, pp. 165–174, W. B. Saunders, Philadelphia.
Fatemi-Nainie, S., Anderson, L. W., and Cheevers, W. P., 1982, Identification of a transforming retrovirus from cultured equine dermal fibrosarcoma, Virology 120:490.
Fisher, A. G.; Collati, E., Ratner, L., Gallo, R. C.; and Wong-Staal, F., 1985, A molecular clone of HTLV-III with biological activity, Nature 316:262.
Foil, L. D., and Issel, C. J., 1990, Transmission of retroviruses by arthropods, Ann. Rev. Entomol. 36:355.
Frankel, A. D., Bredt, D. S., and Pabo, C. O., 1988, Tat protein from human immunodeficiency virus forms a metal-linked dimer, Science 240:70.
Freed, E. O., Myers, D. J., and Risser, R., 1991, Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain, J. Virol. 65:190.
Fujimiya, Y., Perryman, L. E., and Crawford, T. T., 1979, Leukocyte cytotoxicity in a persistent virus infection: Presence of direct toxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus, Infect. Immun. 24:628.
Fukasawa, M., Miuara, J., Hasegawa, A., Morikawa, A., Tsujimoto, H., Miki, K., Kitamura, T., and Hayami, M., 1988, Sequences of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group, Nature 333:457.
Gallaher, W. R., 1987, Detection of a fusion peptide sequence in the transmembrane sequence of human immunodeficiency virus, Cell 50:327.
Gallaher, W. R., Ball, J. M., Garry, R. F., Griffin, M. C., and Montelaro, R. C., 1989, A general model for the transmembrane proteins of HIV and other retroviruses, AIDS Res. Hum. Retroviruses 5:431.
Garvey, K. J., Oberste, S., Eiser, F. E., Braun, M. J., and Gonda, M. A., 1990, Nucleotide sequence and genome organization of biologically active proviruses of the bovine immunodeficiencylike virus, Virology 175:391.
Gatignol, A., Kumar, J. C., Rabson, A., and Jeang, K. T., 1989, Identification of cellular proteins that bind to the human immunodeficiency virus type 1 trns-activation responsive TAR element RNA, Proc. Natl. Acad. Sci. USA 86:7828.
Gelderblom, H. R., 1991, Assembly and morphology of HIV: Potential effect of structure on viral function, AIDS 5:617-638.
Gerencer, M., Valpotic, I., Jukie, B., Tomaskovic, M., and Basic, I., 1989, Qualitative analyses of cellular immune functions in equine infectious anemia show homology with AIDS, Arch. Virol 104:249.
Gibson, C. A., Schlesinger, J. J., and Barrett, A. D. T., 1988, Prospects for a virus nonstructural protein as a subunit vaccine, Vaccine 6:7.
Girard, M., Kieny, M. P., Pinter, A., Barre-Sinoussi, F., Nara, P., Kolbe, H., Kusumi, K., Chaput, A., Reinhart, T., Muchmore, E., Ronco, J., Kaczorek, M., Gomard, E., Gluckman, J. C., and Fultz, P. N., 1991, Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus, Proc. Natl. Acad. Sci. USA 88:542.
Gnann, Jr., J. W., McCormick, J. B., Mitchell, S., Nelson, J. A., and Oldstone, M. B. A., 1987a, Synthetic peptide immunoassay distinguishes HIV type I and HIV type 2 infections, Science 237:1346.
Gnann, Jr., J. W., Nelson, J. A., and Oldstone, M. B. A., 1987b, Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus, J. Virol. 61:2639.
Gonda, M. A., Wong-Staal, F., Gallo, R. C., Clements, J. E., Narayan, O., and Gilden, R. V., 1985, Sequence homology and morphologic similarity of HTLV-III and visna virus, a pathogenic lentivirus, Science 227:173.
Goudsmit, J., 1988, Immunodominant B-cell epitopes of the HIV-1 envelope recognized by infected and immunized hosts, Aids 2 (Suppl 1):S41.
Goudsmit, J., Houwers, D. J., Smit, L., and Nauta, I. M., 1986, LAV/HTLV-III gag gene product p24 shares antigenic determinants with equine infectious anemia virus but not with visna virus or caprine arthritis encephalitis virus, Intervirology 26:169.
Goudsmit, J., Boucher, C. A. B., Meloen, R. H., Smit, L., Epstein, L. G., Van der hoek, L., and Bakker, M., 1988, Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition, Aids 2:157.
Gourdou, I., Mazarin, V., Querat, G., Sauze, N., and Vigne, R., 1989, The open reading frame S of visna virus genome is a trans-activating gene, Virology 171:170.
Grand, R. J. A., 1989, Acylation of viral and eukaryotic proteins, Biochem. J. 258:625.
Grandbastien, M. A., Spielmann, A., and Caboche, M., 1989, Tntl, a mobile retroviral-like transposable element of tobacco isolated by plant cell genetics, Nature 337:376.
Gras, G. S., and Dormant, D., 1991, Antibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocyte cell line, J. Virol. 65:541.
Gras, G., Strub, T., and Dorman, D., 1988, Antibody-dependent enhancement of HIV infection, Lancet i:1285.
Green, M., Ishino, M., and Lowenstein, P. M., 1989, Mutational analysis of HIV-1 tat minimal domain peptides: Identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression, Cell 58:215.
Greene, W. C., and Cullen, B. R., 1990, The rev-rex connection: Convergent strategies for the post-transcriptional regulation of HIV-1 and HTLV-1 gene expression, in: Seminars in Virology: Recent Advances in Retrovirology (Irvin S. Y. Chen, ed.), Vol. 1, pp. 195–204, W. B. Saunders, Philadelphia.
Gregory, R. J., Cheng, S. H., Rich, D. P., Marshall, J., Paul, S., Hehir, K., Ostedgaard, L., Klinger, K. W., Welsh, M. J., and Smith, A. E., 1990, Expression and characterization of the cystic fibrosis transmembrane conductance regulator, Nature 347:382.
Haase, A., 1986, Pathogenesis of lentivirus infections, Nature 322:130.
Haffer, R., Koertje, W., Derr, J., and Beckenhauer, W., 1990, Evaluation of immunosuppressive effect and efficacy of an improved potency feline leukemia vaccine, Vaccine 8:12.
Hahn, B. H., Shaw, G. W., Taylor, M. E., Redfield, R. R., Markham, P. D., Salahuddin, S. Z., Wong-Staal, F., Gallo, R. C., Parks, E. S., and Parks, W. P., 1986, Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS, Science 232:1548.
Harris, J. D., Blum, H., Scott, J., Traynor, P., Ventura, P., and Haase, A., 1984, Slow virus visna: Reproduction in vitro of virus from extrachromasomal DNA, Proc. Natl. Acad. Sci. USA 81:7212.
Hawkins, J. A., Adams, W. V., Wilson, B. H., Issel, C. J., and Roth, E. E., 1976, Transmission of equine infectious anemia virus by Tabanus fuscicostatus, J. Am. Vet. Med. Assoc. 168:63.
Hayman, E., Pal, B., and Roy-Burman, P., 1977, RNA tumor virus phosphoproteins: Evidence for virus specificity of phosphorylation, J. Gen. Virol. 36:459.
Helseth, E., Olshevsky, U., Gavuzda, D., Ardman, B., Haseltine, W., and Sodroski, J., 1990, Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion, J. Virol. 64:6314.
Henderson, L. E., Sowder, R. C., Smythers, G. W., and Oroszlan, S. T., 1987, Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins, J. Virol. 61:1116.
Hess, J. L., Clements, J. E., and Narayan, O., 1985, Cis- and trans-acting transcriptional regulation of visna virus, Science 229:482.
Hess, J. L., Small, J. A., and Clements, J. E., 1989, Sequences in the visna long terminal repeat that control transcriptional activity and respond to trans-activation: Involvement of AP-1 sites in basal activity and trans-activation, J. Virol. 63:3001.
Hizi, A., Henderson, L. E., Copeland, T. D., Sowder, R. C., Hixson, C. V., and Oroszlan, S., 1987, Characterization of MMTV gag-pol gene products and the ribosomal frameshift site by protein sequencing, Proc. Natl Acad. Sci. USA 84:7041.
Holland, S. M., Ahmad, N., Maitra, R. K., Wingfield, P., and Venkatesan, S., 1990, Human immunodeficiency virus rev protein recognizes a target sequence in rev-responsive element RNA within the context of RNA secondary structure, J. Virol. 64:5966.
Homsy, J., Tateno, M., and Levy, F. A., 1988, Antibody-dependent enhancement of HIV infection, Lancet i: 1285.
Homsy, J., Meyer, M., Tateno, M., Clarkson, S., and Levy, J. A., 1989, The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells, Science 244:1357.
Homsy, J., Meyer, M., and Levy, J. A., 1990, Serum enhancement of human immunodeficiency virus (HIV) infection correlates with disease in HIV-infected individuals, J. Virol. 64:1437.
Hoover, E., Schaller, J., Mathes, L., and Olsen, R., 1977, Passive immunity to feline leukemia virus: Evaluation of immunity from dams naturally infected and experimentally vaccinated, Infect. Immun. 16:54.
Hoover, E. A., Perigo, N. A., Quackenbush, S. L., Mathiason-DuBard, C. K., Overbaugh, J. M., Kloetzer, W. S., Elder, J. E., and Mullins, J. L, 1991, Protection against feline leukemia virus infection by use of an inactivated virus vaccine, J. Am. Vet. Med. Assoc. 199:1392.
Hu, S. L., Fultz, P. N., McClure, H. M., Eichberg, J. W., Thomas, E. K., Zarling, S., Singhal, M. C., Kosowski, S. G., Swenson, R. R., Anderson, D. C., and Todaro, G., 1987, Effects of immunization with vaccina-HIV env recombinant on HIV infection of chimpanzees, Nature 328:721.
Hunsmann, G., Moennig, V., and Schafer, W., 1975, Properties of murine leukemia virus. IX: Active and passive immunization of mice against Friend leukemia with isolated viral gp71 glycoprotein and its corresponding antiserum, Virology 66:327.
Hunsmann, G., Schneider, J., and Schulz, A., 1981, Immunoprevention of Friend virus-induced erythroleukemia by vaccination with viral envelope glycoprotein complexes, Virology 113:602.
Hunter, E., and Swanstrom, R., 1990, Retroviral envelope glycoproteins, in: Current Topics in Microbiology and Immunology: Retroviruses: Strategies of Replication (R. Swanstrom and P. K. Vogt, eds.), Vol. 157, pp. 188–253, Springer-Verlag, New York.
Hussain, K. A., Issel, C. J., Schnorr, K. L., Rwambo, P. M., and Montelaro, R. C., 1987, Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: Epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies, J. Virol. 61:2956.
Hussain, K. A., Issel, C. J., Schnorr, K. L., Rwambo, P. M., West, M., and Montelaro, R. C., 1988a, Antigenic mapping of the envelope proteins of equine infectious anemia virus: identification of a neutralization domain and a conserved region on glycoprotein 90, Arch. Virol. 98:213.
Hussain, K. A., Issel, C. J., Rwambo, P. W., Arnizaut, A. B., Ball, J. M., Schnorr, K. L., and Montelaro, R. C., 1988b, Identification of gag precursor of equine infectious anemia virus with monoclonal antibodies to the major viral core protein, p26, J. Gen. Virol. 69:1719.
Issel, C. J., and Adams, W. V., 1979, Serologie survey for equine infectious anemia virus in Louisiana, J. Am. Vet. Med. Assoc. 174:286.
Issel, C. J., and Coggins, L., 1979, Equine infectious anemia: Current knowledge, J. Am. Vet. Med. Assoc. 174:727.
Issel, C. J., and Foil, L. D., 1984, Studies on equine infectious anemia virus transmission by insects, J. Am. Vet. Med. Assoc. 184:293.
Issel, C. J., Adams, W. V., Meek, L., and Ochua, R., 1982, Transmission of equine infectious anemia virus from horses without clinical signs of the disease, J. Am. Vet. Med. Assoc. 180:272.
Issel, C. J., Adams, W. V., and Foil, L. D., 1985, Prospective study of the progeny of inapparent carriers of equine infectious anemia virus, Am. J. Vet. Res. 46:114.
Issel, C. J., Rushlow, K. E., Foil, L. D., and Montelaro, R. C., 1988a, A perspective on equine infectious anemia with an emphasis on vector transmission and genetic analysis. Vet. Microbiol. 17:251.
Issel, C. J., Rwambo, P. M., and Montelaro, R. C., 1988b, Evolution of equine infectious anemia diagnostic tests: Recognition of a need for detection of anti-EIAV glycoprotein antibodies, in: Equine Infectious Diseases (D. G. Powell, ed.), Vol. 5, pp. 196–200, The University Press of Kentucky, Lexington, KY.
Issel, C. J., Horohov, D. W., Lea, D. F., Adams, W. V., Hagius, S. D., McManus, J. M., Allison, A. C., and Montelaro, R. C., 1992, Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus, J. Virol. 66:3398.
Jacks, T., 1990, Translational suppression in gene expression in retroviruses and retrotransposons, in: Current Topics in Microbiology and Immunology: Retroviruses’ Strategy and Replication (R. Swanstrom and P. K. Vogt, eds.), Vol. 157, pp. 93–124, Springer-Verlag, New York.
Jacks, T., Power, M. D., Masiarz, F. R., Luciw, P. A., Barr, P. J., and Varmus, H. E., 1988, Characterization of ribosomal frameshifting in HIV-1 gag-pol expression, Nature 331:280.
Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. L, Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., Putney, S. D., and Matthews, T. J., 1989, Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein, Proc. Natl. Acad. Sci. USA 86:6768.
Johnson, M. S., McClure, M. A., Feng, D. R., Gray, J., and Doolittle, R. F., 1986, Computer analysis of retroviral pol genes: Assignment of enzymatic functions to specific sequences and homologies with non-viral enzymes, Proc. Natl. Acad. Sci. USA 83:7648.
Katoh, I., Yasunaga, T., Ikawa, Y., and Yoshinaka, Y., 1987, Inhibition of retro viral protease activity by an aspartyl proteinase inhibitor, Nature 329:654.
Kawakami, T., Sherman, L., Dahlberg, J., Gazit, A., Yaniv, A., Tronick, S. R., and Aaronson, S. A., 1987, Nucleotide sequence analysis of equine infectious anemia virus proviral DNA, Virology 158:300.
Kemeny, L. J., Mott, L. O., and Pearson, J. E., 1971, Titration of equine infectious anemia virus: Effects of dosage on incubation time and clinical symptoms, Cornell Vet. 61:687.
Kestler, H., Kodama, T., Ringler, D., Marthas, M., Pedersen, N., Lackner, A., Regier, D., Sehgal, P., Daniel, M., King, N., and Desrosiers, R., 1990, Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus, Science 248:1109.
Kim, C. H., and Casey, J. W., 1992, Genomic variation and segregation of equine infectious anemia virus during acute infection, J. Virol. 66:3879.
Kim, S., Byrn, R., Groopman, J., and Baltimore, D., 1989, Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression, J. Virol. 63:3708.
Kleiser, C., Schneider, J., Bayer, H., and Hunsmann, G., 1986, Immunoprevention of Friend leukemia virus-induced erythroleukemia by vaccination with aggregated gp70, J. Gen. Virol. 67:1901.
Klimkait, T., Strebel, K., Hoggan, M. D., Martin, M. A., and Orenstein, J. M., 1990, The human immunodeficiency virus type-1-specific protein vpu is required for efficient virus maturation and release, J. Virol. 64:621.
Kobayashi, K., and Kono, Y., 1967a, Propagation and titration of equine infectious anemia virus in horse leukocyte culture, Natl. Inst. Anim. Health Q. (Tokyo) 1:8.
Kobayashi, K., and Kono, Y., 1967b, Serial passage of equine infectious anemia virus in horse leukocyte culture, Natl. Inst. Anim. Health Q. (Tokyo) 1:1.
Kono, Y., 1988, Antigenic variation of equine infectious anemia virus as detected by virus neutralization, Arch. Virol. 98:91.
Kono, Y., and Yokomizo, Y., 1968, Attempts to cultivate the equine infectious anemia virus in various types of cells, Natl. Inst. Anim. Health Q. (Tokyo) 8:182.
Kono, Y., Kobayashi, K., and Fukunaga, Y., 1970a, Immunization of horse against equine infectious anemia (EIA) with an attenuated EIA virus, Natl. Inst. Anim. Health. Q. (Tokyo) 10:113.
Kono, Y., Yoshino, Y., and Fukanaga, Y., 1970b, Growth characteristics of equine infectious anemia virus in horse leukocyte cultures. Arch. Gesamte Virusforsch 30:252.
Kono, Y., Kobayashi, K., and Fukunaga, Y., 1971, Serological comparisons among various strains of equine infectious anemia virus, Arch. Gesamte Virusforsch 34:332.
Kono, Y., Kobayashi, K., and Fukunaga, Y., 1973, Antigenic drift of equine infectious anemia virus in chronically infected horses, Arch. Gesamte Virusforsch 41:1.
Kono, Y., Hirasawa, K., Fukunaga, Y., and Taniguchi, T., 1976, Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs, Natl. Inst. Anim. Health Q. (Tokyo) 16:8.
Kowalski, M., Potz, J., Basiripour, L., Doreman, T., Chun, W., Terwilleger, E., Dayton, A., Rosen, C., Haseltine, W., and Sodroski, J., 1987, Functional regions of the envelope glycoprotein of human immunodeficiency virus type I, Science 237:1351.
Kozak, M., 1989, The scanning model for translation: An update, J. Cell Biol. 108:229.
Kyte, J., and Doolittle, R. F., 1982, A simple method for displaying the hydropathic character of a peptide, J. Mol. Biol. 157:105.
Lasky, L. A., Nakamura, G., Smith, D. H., Fennie, C., Shimasaki, C., Patzer, E., Berman, P., Gregory, T., and Capon, D. J., 1987, Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor, Cell 50:975.
LeGrice, S. F. J., Panin, M., Kalayjian, R. C., Richter, N. J., Keith, G., Darlix, J. L., and Payne, S. L., 1992, Purification and recombination of recombinant equine infectious anemia virus reverse transcriptase, J. Virol. 65:7004.
Leonard, C. K., Spellman, M. W., Riddle, L., Harris, R. J., Thomas, J. N., and Gregory, T. J., 1990, Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells, J. Biol. Chem. 265:10373.
Levy, J., 1977, C-type RNA viruses and autoimmune disease, in: Autoimmunity (N. Talal, ed.), pp. 403–452, Academic Press, New York.
Levy, J., 1990, Changing concepts in HIV infection: Challenges for the 1990s, Aids 4:1051.
Lewis, M., Mathes, L., and Olsen, R., 1981, Protection against feline leukemia by vaccination with a subunit vaccine, Infect. Immun. 34:888.
Lignee, M., 1843, Memoire et observations sur une maladie de sang, connue sous le nom d’anhemie hydrohemie, cachexie aquiuse du cheval, Rec. Med. Vet. 1843:20.
Long, C. W., Henderson, L. E., and Oroszlan, S., 1980, Isolation and characterization of lowmolecular-weight DNA-binding proteins from retroviruses, Virology 63:491.
Lu, Y., Stenzel, M., Sodroski, M., and Haseltine, W. A., 1989, Effects of long terminal repeat mutations on human immunodeficiency virus type 1 replication, J. Virol. 63:4115.
Lu, Y., Touzjian, N., Stenzel, M., Dorfman, T., Sodroski, J. G., and Haseltine, W. A., 1990, Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1, J. Virol. 64:5226.
Ma, X., Kakai, K., Sinangil, F., Golub, D., and Volsky, D. J., 1990, Interaction of noncytopathic human immunodeficiency virus type-1 (HIV-1) with target cells: Efficient virus entry followed by delayed expression of its RNA and protein, Virology 176:184.
Magnac, C., de Saint Martin, J., Pidard, D., Legrand, C., and Dighiero, G., 1990, Platelet antibodies in serum of patients with human immunodeficiency viru (HIV) infection, AIDS Res. Hum. Retroviruses 6:1443.
Malim, M. H., Bohnlein, S., Hauber, J., and Cullen, B. R., 1989, Functional dissection of the HIV-1 rev tnms-activator: Derivation of a irons-dominant repressor of rev function, Cell 58:205.
Malmquist, W. A., Barnett, D., and Decvar, C. S., 1973, Production of equine infectious anemia in a persistently infected cell line, Arch. Gesamte Virusforsch 42:361.
Margolit, H., Spouge, J. L., Cornette, J. L., Cease, K. B., Delisi, C., and Berzofsky, J. A., 1987, Prediction of immunodominant helper T cell antigenic sites from the primary sequence, J. Immunol. 138:2213.
Martin, S., Courtney, R. J., Fowler, G., and Rouse, B. T., 1988, Herpes simplex virus type 1—specific cytotoxic T lymphocytes recognize virus nonstructural proteins, J. Virol. 62:2265.
Marx, P., Pedersen, N., Lerche, M., Osborn, K., Lowenstine, L., Lachner, A., Maul, D., Kwang, H., Kluge, J., Zaiss, C., Sharpe, V., Spinner, A., Allison, A., and Gardner, M., 1986, Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type-D retrovirus vaccine, J. Virol. 60:431.
Mastro, J., Lewis, M., Mathes, L., Sharpee, R., Tarr, M., and Olsen, R., 1986, Feline leukemia vaccine: Efficacy, contents, and probable mechanism, Vet. Immunol. Immunopathol. 11:205.
Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T., Hoshino, H., Javaherian, K., Takatsuki, K., and Putney, S., 1988, Characterization of a human immunodeficiency virus neutralization monoclonal antibody and mapping of the neutralizing epitope, J. Virol. 62:2107.
McClure, J. J., Lindsay, W. A., Taylor, W., Ochoa, R., Issel, C. J., and Coulter, S. J., 1982, Ataxia in four horses with equine infectious anemia, J. Am. Vet. Med. Assoc. 180:279.
McClure, M. A., Johnson, M. S., and Doolittle, R. F., 1987, Relocation of a protease-like gene segment between two retroviruses, Proc. Nail. Acad. Sci. USA 84:2693.
McClure, M. A., Johnson, M. S., Feng, D. F., and Doolittle, R. F., 1988, Sequence comparisons of retroviral proteins: Relative rates of change and general phylogeny, Proc. Natl. Acad. Sci. USA 85:2469.
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Hosek, J. C., Reyes, G. R., and Weissman, I. L., 1988, Endoproteolytic cleavage of gp160 is required for activation of human immunodeficiency virus, Cell 53:55.
McGeoch, D. V., 1990, Protein sequence comparisons show that the pseudoproteases encoded by poxviruses and certain retroviruses belong to the deoxyuridine triphosphatase family, Nucleic Acids Res. 18:4105.
McGuire, T. C., 1976, Suppression of synthesis of an IgG subclass in a persistent viral infection. Immunology 30:17.
McGuire, T. C., and Henson, J. B., 1973, Equine infectious anemia-pathogenesis of persistent viral infection, Perspect. Virol. 8:229.
McGuire, T. C., Henson, J. B., and Burger, D., 1969a, Complement (C3)-coated red blood cells following infection with the virus of equine infectious anemia, J. Immunol. 103:293.
McGuire, T. C., Henson, J. B., and Quist, S. E., 1969b, Viral-induced hemolysis in equine infectious anemia, Am. J. Vet. Res. 30:2091.
McGuire, T. C., Crawford, T. B., and Henson, J. B., 1971, Immunofluorescent localization of equine infectious anemia virus in tissue, Am. J. Pathol. 61:283.
McGuire, T. C., Crawford, T. B., and Henson, J. B., 1972, Equine infectious anemia: Detection of infectious virus antibody complexes in the serum, Immunol. Commun. 1:545.
McGuire, T., Adams, D., Johnson, G., Klevjer-Anderson, P., Barbee, D., and Gorham, J., 1986, Retrovirus challenge of vaccinated or persistently infected goats causes acute arthritis, Am. J. Vet. Res. 47:537.
McGuire, T. C., Lacy, P. A., and O’Rourke, K. I., 1990a, cDNA sequence of the env gene of a pathogenic equine infectious anemia lentivirus variant, Nucleic Acids Res. 18:196.
McGuire, T. C., O’Rourke, K. I., and Perryman, L. E., 1990b, Immunopathogenesis of equine infectious anemia lentivirus disease, in: Developments in Biological Standardization: Progress in Animal Retroviruses (D. Gaudry and W. Hennessen, eds.), Vol. 72, pp. 31–39, S. Karger, Basel.
Mcllwraith, W., and Kitchen, N. D., 1978, Neurologic signs and neuropathology associated with a case of equine infectious anemia, Cornell Vet. 68:238.
Mercer, A. A., Fraser, K. M., Stockwell, P. A., and Robinson, A. J., 1989, A homologue of retro-viral pseudoprotease in the parapoxvirus, Orf virus, Virology 172:665.
Meric, C., and Goff, S. P., 1989, Characterization of murine leukemia virus mutants with singleamino-acid substitutions in the cys-his box of the nucleocapsid protein, J. Virol. 63:1558.
Miller, M. A., Garry, R. F., Jaynes, J. M., and Montelaro, R. C., 1991, A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides, AIDS Res. Hum. Retroviruses 7:439.
Modrow, S., Hahn, B. H., Shaw, G. M., Callo, R. C., Wong-staal, F., and Wolf, H., 1987, Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: Prediction of antigenic epitopes in conserved and variable regions, J. Virol. 61:570.
Montagnier, L., Dauguet, C., Axler, C., Chamaret, J., Gruest, M. T., Nugeyre, F., Rey, F., Barresinoussi, F., and Chermann, J. C., 1984, A new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immunodeficiency syndrome: Structural and antigenic relatedness with equine infectious anemia virus, Ann. Virol. (Inst. Pasteur) 135E:119.
Montelaro, R. C., and Issel, C. J., 1990, Immunologic management of equine infectious anemia virus: A model for AIDS vaccine development, in: Animal Models for AIDS (H. Schellekens and M. Horzinek, eds.), pp. 221–232, Elsevier, Amsterdam.
Montelaro, R. C., Sullivan, S. J., and Bolognesi, D. P., 1978, An analysis of type-C retrovirus polypeptides and their associations in the virion, Virology, 84:19.
Montelaro, R. C., Lohrey, N., Parekh, B., Blakeney, E. W., and Issel, C. J., 1982, Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus, J. Virol. 42:1029.
Montelaro, R. C.; Parekh, B., Orrego, A., and Issel, C. J., 1984a, Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus, J. Biol. Chem. 259:10539.
Montelaro, R. C., West, M., and Issel, C. J., 1984b, Antigenic reactivity of the major glycoprotein of equine infectious anemia virus, a retrovirus, Virology 136:368.
Montelaro, R. C., Robey, G. W., West, M. D., Issel, C. J., and Fischinger, P. J., 1988, Characterization of the serological cross-reactivity between glycoproteins of the human immunodeficiency virus and equine infectious anemia virus, J. Gen. Virol. 69:1711.
Montelaro, R. C., Ball, J. M., and Issel, C. J., 1989, Characterization of EIAV immunogenicity during persistent infections: Humoral responses and antigen targets, in: Developments Biological Standardization, Vol. 72: Progress in Animal Retroviruses (D. Gaudry and W. Hennessen, eds.), pp. 19–30.
Montelaro, R., Rushlow, K., Ball, J., Chong, Y., and Issel, C., 1991, Immunological management of equine infectious anemia virus and its implications for AIDS vaccine development, in: AIDS Research Review, Vol. 1 (W. Koff, F. Wong-Staal, and R. Kennedy, eds.), Marcel Dekker, Inc., New York, pp. 219–234.
Murphey-Corb, M., Martin, L., Davison-Fairburn, B., Montelaro, R. C., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S. D., Allison, A. C., and Eppstein, D. A., 1989, A formalin-inactivated whole SIV vaccine confers protection in macques, Science 246:1293.
Murphey-Corb, M., Montelaro, R. C., Miller, M., West, M., Martin, L. N., Davison-Fairburn, B., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S. D., Allison, A. C., and Eppstein, D. A., 1991, Efficacy of simian immunodeficiency virus (SIV/Delta B670) subunit vaccines: Evaluation of glycoprotein-enriched and glycoprotein-depleted vaccine preparations, Aids 5:655.
Nakajima, H., Norcross, N. L., and Coggins, L., 1972, Demonstration of antigenic identity between purified EIA virus and an antigen extracted from infected horse spleen, Infect. Immun. 6:416.
Nakamura, H., Hayami, M., Ohta, Y., Ishikawa, K., Tsujimoto, H., Kiyokawa, T., Yoshida, M., Sasagawa, A., and Honjo, S., 1987, Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-1 by immunization with viral env gene products produced in Escherichia coli, Int. J. Cancer 40:403.
Nakatani, Y., Horikoshi, M., Brenner, M., Yamamoto, T., Besnard, F., Roeder, R. G., and Freese, E., 1990, A downstream initiation element required for efficient TATA box binding and in vitro function of TFIID, Nature 348:86.
Narayan, O., and Clements, J. E., 1989, Biology and pathogenesis of lentiviruses, J. Gen. Virol. 70:1617.
Narayan, O., and Clements, J. E., 1990, Lentiviruses, in: Virology (B. N. Fields and D. M. Knipe, eds.), pp. 1571–1589, Raven Press, New York.
Nathanson, N., Martin, J., Georgsson, G., Palsson, P., Lutley, R., and Petursson, N., 1981, J. Comp. Pathol 91:185.
Noiman, S., Yaniv, A., Sherman, L., Tronick, S. R., and Gazit, A., 1990, Pattern of transcription of the genome of equine infectious anemia virus, J. Virol. 64:1839.
Norrby, E., Chiodi, F., Whalley, A., Parks, E., Naucler, A., Costa, C. M., Torstensson, R., and Biberfeld, G., 1989, Site-directed enzyme-linked immunosorbent assay with a synthetic simian immunodeficiency virus SIVmac peptide identifying antibodies against the HIV-2 transmembrane glycoprotein, Aids 3:17.
Nowak, M. A., May, R. M., and Anderson, R. M., 1990, The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease, Aids 4:1095.
Olsen, R., Hoover, E., Schaller, J., Mathes, L., and Wolff, L., 1977, Abrogation of resistence to feline oncornavirus disease by immunization with killed FeLV, Cancer Res. 37:2082.
Olshevsky, U., Helseth, E., Furman, C., Li, J., Haseltine, W., and Sodrowski, J., 1990, Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding, J. Virol. 64:5701.
O’Rourke, K., Perryman, L. E., and McGuire, T. C., 1988, Antiviral, antiglycoprotein, and neutralizing antibodies in foals with equine infectious anemia virus, J. Gen. Virol. 69:667.
O’Rourke, K. L, Perryman, L. E., and McGuire, T. C., 1989, Cross neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus, Vet. Immunol. Immunopathol. 23:41.
O’Rourke, K. I., Besola, M. L., and McGuire, T. C., 1991, Proviral sequences detected by polymerase chain reaction in peripheral blood cells of horses with equine infectious anemia lentivirus, Arch. Virol. 117:109.
Oroszlan, S., and Gilden, R., 1980, Primary structure analysis of retrovirus proteins, in: Molecular Biology of RNA Tumor Viruses (J. Stephenson, ed.), pp. 299–345, Academic Press, New York.
Oroszlan, S., and Luftig, R. B., 1990, Retroviral proteinases, in: Current Topics in Microbiology and Immunology: Retroviruses’ Strategies of Replication (R. Swanstrom and P. K. Vogt, eds.), Vol. 157, pp. 153–185, Springer-Verlag, New York.
Orrego, A., Issel, C. J., Montelaro, R. C., and Adams, W. V., 1982, Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies, Am. J. Vet. Res. 43:1556.
Osterhaus, A., Weijer, K., Uytdehaag, F., Jarrett, O., Sundquist, B., and Morein, B., 1985, Induction of protective immune responses in cats by vaccination with feline leukemia virus iscom, J. Virol. 135:591.
Owens, R. J., Tanner, C. C., Mulligan, M. J., Srinivas, R. V., and Compans, R. W., 1990, Oligopeptide inhibitors of HIV-induced syncytium formation, AIDS Res. Hum. Retroviruses 6:1289.
Ozel, M., Pauli, G., and Gelderblom, H. R., 1988, The organization of the envelope projections on the surface of HIV, Arch. Virol 100:255.
Palker, T. J., Matthews, T. J., Clark, M. E., Cianciole, G. J., Randall, R. R., Langlois, A. J., White, G. C., Safai, B., Snyderman, R., Bolognesi, D. P., and Haynes, B. F., 1987, A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope, Proc. Natl. Acad. Sci. USA 84:2479.
Palker, T. J., Clark, M. E., Langlois, A. J., Matthews, T. J., Weinhold, K. J., Randall, R. R., Bolognesi, D. P., and Haynes, B. F., 1988, Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides, Proc. Natl. Acad. Sci. USA 85:1932.
Parekh, B., Issel, C. J., and Montelaro, R. C., 1980, Equine infectious anemia virus, a putative lentivirus, contains polypeptides analogous to prototype-C oncornaviruses, Virology 107:520.
Parker, J. M. R., Guo, D., and Hodges, R. S., 1986, New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites, Biochemistry 25:5425.
Payne, S. L., Fang, F. D., Liu, C. P., Dhruva, B. R., Rwambo, P., Issel, C. J., and Montelaro, R. C., 1987a, Antigenic variation and lentivirus persistence: Variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV, Virology 161:321.
Payne, S. L., Salinovich, O., Nauman, S. M., Issel, C. J., and Montelaro, R. C., 1987b, Course and extent of variation of equine infectious anemia virus during parallel infections, J. Virol. 61:1266.
Payne, S. L., Ball, J. M., Issel, C. J., Rushlow, K., and Montelaro, R. C., 1988, Envelope gene variation in equine infectious anemia virus: Implications for vaccine development, in: Modern Approaches to New Vaccines Including the Prevention of AIDS, Article No. 36, pp. 297–302, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Payne, S. L., Rushlow, K., Dhruva, B. D., Issel, C. J., and Montelaro, R. C., 1989, Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli, Virology 172:609.
Pearl, L. H., and Taylor, W. R., 1987, A structural model for the retroviral proteases, Nature 329:351.
Pedersen, N., Johnson, R., and Ott, R., 1985, Evaluation of commercial feline leukemia virus vaccine for immunogenicity and efficacy, Feline Pract. 15:7.
Perry, S. T., Flaherty, M. T., Kelley, M. J., Clabough, D. L., Tronick, S. R., Coggins, L., Whetter, L., Lengel, C. R., and Fuller, F., 1992, The surface unit protein gene region of equine infectious anemia virus is not an important determinant of tropism in vitro, J. Virol. 66:4085.
Perryman, L. E.; McGuire, T. C., Banks, K. L., and Henson, J. B., 1971, Decreased C3 levels in a chronic virus infection: Equine infectious anemia, J. Immunol. 106:1074.
Perryman, L. E., O’Rourke, K. I., and McGuire, T. C., 1988, Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection, J. Virol. 61:3073.
Perryman, L. E., O’Rourke, K. I., Mason, P. H., and McGuire, T. C., 1990, Equine monoclonal antibodies recognize common epitopes on variants of equine infectious anemia virus, Immunology 71:592.
Peterlin, B. M., and Luciw, P. A., 1988, Molecular biology of HIV, Aids 2:S29.
Phillips, T. R., Talbott, R. L., Lamont, C., Muir, S., Lovelace, K., and Elder, J. H., 1990, Comparison of two host cell range variants of feline immunodeficiency virus, J. Virol. 64:4605.
Pinter, A., and Honnen, W. J., 1983, Topography of murine leukemia virus envelope proteins; characterization of membrane components, J. Virol. 46:1056.
Pollack, R. V., and Scarlett, J., 1990, Randomized blind trial of a commercial FeLV vaccine, J. Am. Vet. Med. Assoc. 196:611.
Pomerantz, R. J., Trono, D., Feinberg, M. B., and Baltimore, D., 1990, Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: A molecular model for latency, Cell 61:1271.
Prats, A. C., Sarih, L., Gabus, C., Litvak, S., Keith, G., and Darlix, J. L., 1988, Small finger protein of avian and murine retroviruses has nucleic acid annelaing activity and positions the replication primer tRNA onto genomic RNA, EMBO J. 7:1777.
Preston, B. D., Poiesz, B. J., and Loeb, L. A., 1988, Fidelity of HIV-1 reverse transcriptase, Science 242:1168.
Priel, E., Showalter, S. D., Roberts, M., Oroszlan, S., Segal, S., Aboud, M., and Blair, D. G., 1990, Topoisomerase I activity associated with human immunodeficiency virus (HIV) particles and equine infectious anemia virus core, EMBO J. 9:4167.
Priel, E., Showalter, S. D., Roberts, M., Oroszlan, S., and Blair, D. G., 1991, The topoisomerase inhibitor, camptothecin, inhibits equine infectious anemia virus replication in chronically infected CF2 Th cells, J. Virol. 65:4137.
Puddington, L., Bevan, M. J., Rose, J. K., and Lefrancois, L., 1986, N protein is the predominant antigen of vesicular stomatitis virus-specific-cytotoxic T cells, J. Virol. 60:708.
Putney, S. D., and Montelaro, R. C., 1990, Immunobiology and immunochemistry of lentiviruses, in: Immunochemistry of Viruses (A. R. Neurath and M. V. H. Vanlegenmortely, eds.), Vol. 2, Elsevier Biochemical Press, Amsterdam.
Rabson, A. B., Daugherty, D. F., Venkatesan, S., Boulukos, K. E., and Benn, S. I., 1985, Transcription of novel open reading frames of AIDS retrovirus during infection of lymphocytes, Science 229:1388.
Rasmussen, L., Battles, J. K., Ennis, W. H., Nagashima, K., and Gonda, M. A., 1990, Characterization of virus-like particles produced by a recombinant baculovirus containing the Gag genes of the bovine immunodeficiency-like virus, Virology 178:435-451.
Rasty, S., Dhruva, B. R., Schiltz, R. L., Shih, D. S., Issel, C. J., and Montelaro, R. C., 1990, Proviral DNA integration and transcriptional patterns of equine infectious anemia virus during persistent and cytopathic infections, J. Virol. 64:86.
Reitz, Jr., M. S., Wilson, C., Naugle, C., Gallo, R. C., and Robert-Guroff, M., 1988, Generation of a neutralization-resistant variant of HIV-I is due to selection for a point mutation in the envelope gene, Cell 54:57.
Rice, A. P., and Carlotti, F., 1990, Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat proteins, J. Virol. 64:6018.
Rice, N. R., and Coggins, L., 1979, Synthesis of long complementary DNA in the endogenous reaction of equine infectious anemia virus, J. Virol. 29:907.
Rice, N. R., Simek, S., Ryder, O. A., and Coggins, L., 1978, Detection of proviral DNA in horse cells infected with equine infectious anemia virus, J. Virol. 16:577.
Rice, N. R., Lequarre, A. S., Casey, J. W., Lahn, S., Stephens, R. M., and J. Edwards, 1989, Viral DNA in horses infected with equine infectious anemia virus, J. Virol. 63:5194.
Rice, N. R., Henderson, L. E., Sowder, R. C., Copeland, T. D., Oroszlan, S., and Edwards, J. F., 1990, Synthesis and processing of the transmembrane envelope protein of equine infectious anemia virus, J. Virol. 64:3770.
Roberts, M. M., and Oroszlan, S., 1989, The preparation and characterization of intact capsids of equine infectious anemia virus, Biochem. Biophys. Res. Commun. 160:486.
Roberts, M. M., and Oroszlan, S., 1990, The action of retroviral proteases in various phases of virus replication, in: Retroviral Proteases: Control of Maturation and Morphogenesis (L. H. Pearl, ed.), pp. 131–139, Macmillan, New York.
Robinson, W. E., Montefiori, D. C., and Mitchell, W. M., 1988, Antibody-dependent enhancement of human immunodeficiency virus type 1 infection, Lancet i:790.
Robinson, W. E., Montefiori, D. C., Mitchell, W. M., Prince, A. M., Alter, H. J., Dreesman, G. R., and Eichberg, J. W., 1989, Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1 infected and passivelyimmunized chimpanzees, Proc. Natl. Acad. Sci. USA 86:4710.
Rosen, C., and Pavlakis, G. N., 1990, Tat and Rev: Regulators of HIV gene expression, Aids 4:499.
Rossmanith, W., and Horvath, E., 1989, Ein Western-blot-test zur serologischen diagnose der infektiösen anamie der pferde, J. Vet. Med. 36:49.
Rothbard, J. B., and Taylor, W. R., 1988, A sequence pattern common to T cell epitopes, EMBO J. 7:93.
Rous, P., 1911, A sarcoma of the fowl transmissible by an agent separable from the tumor cells, J. Exp. Med. 13:397.
Roy, S., Parkin, N. T., Rosen, C., Itovitch, J., and Sonenberg, N., 1990, Structural requirements for trans-activation of HIV-1 long terminal repeat-directed gene expression by tat: Importance of base pairing, loop sequence, and bulges in the tat-responsive sequence, J. Virol. 64:1402.
Ruegg, C. L., Monell, C. R., and Strand, M., 1989, Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1, J. Virol. 63:3257.
Rushlow, K. E., Olsen, K., Stiegler, G., Payne, S. L., Montelaro, R. C., and Issel, C. J., 1986, Lentivirus genomic organization: The complete nucleotide sequence of the env gene region of equine infectious anemia virus, Virology 155:309.
Rushlow, K. E., Chong, Y. H., Ball, J. M., Issel, C. J., and Montelaro, R. C., 1990, Evaluation of protective host immune responses during persistent infection with EIAV, in: Proceeding 5th Colloque des Cent Garde: Retroviruses of Human AIDS and Related Animal Diseases (M. Girard and L. Valette, eds.), Foundation Merieux, Lyon, France, pp. 133–138.
Rushlow, K., Peng, X.-X., Montelaro, R. C., and Shih, D. S., 1992, Expression of the protease gene of equine infectious anemia virus in Escherichia coli: Formation of mature processed enzyme and specific cleavage of the Gag precursor, Virology 188:396.
Rwambo, P. M., Issel, C. J., Adams, W. V., Hussain, K. A., Miller, M., and Montelaro, R. C.;1990a, Equine infectious anemia virus: Humoral responses of recipient ponies and antigenic variation during persistent infection, Arch. Virol. 111:199.
Rwambo, P. M., Issel, C. J., Hussain, K. A., and Montelaro, R. C., 1990b, In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV), Arch. Virol. 111:275.
Saag, M. S., Hahn, B. H., Gibbons, J., Li, Y., Parks, E. S., Parks, W. P., and Shaw, G. M., 1988, Extensive variation of human immunodeficiency virus type-1 in vivo. Nature 334:440.
Salerno, R., Lehman, E., Larson, V., and Helleman, R., 1978, Feline leukemia virus envelope glycoprotein vaccine: Preparation and evaluation of immunizing potency in the guinea pig and cat, J. Natl. Cancer Inst. 16:54.
Salinovich, O., and Montelaro, R. C., 1986, Comparison of glycoproteins by two-dimensional mapping of glycosylated peptides, Anal. Biochem. 157:19.
Salinovich, O., Payne, S. L., Montelaro, R. C., Hussain, K. A., Issel, C. J., and Schnorr, K. L., 1986, Rapid emergence of novel antigenic and genetic variants of equine infectious anemia virus during persistent infection, J. Virol. 57:71.
Saltarelli, M., Querat, G., Konings, C. A. M., Vigne, R., and Clements, J. E., 1990, Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus, Virology 179:347.
Saman, E., Breugelmans, K., Heyndrickx, L., and Merregaert, J., 1990, The open reading frame ORF S3 of equine infectious anemia virus is expressed during the viral life cycle, J. Virol. 64:6319.
Schütz, R. L., Shih, D. S., Rasty, S., Montelaro, R., and Rushlow, K. E., 1992, Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2, J. Virol. 66:3455.
Schiltz, R. L., Shih, D. S., Rasty, S., Montelaro, R. C., and Rushlow, K. E., 1991, Equine infectious anemia virus gene expression: Characterization of the RNA splicing pattern and protein products encoded by open reading frames S1 and S2, J. Virol. 66:3455.
Schneider, J., and Kent, S. B. H., 1988, Enzymatic activity of a synthetic 99 residue protein corresponding to the putative HIV-1 protease, Cell 54:363.
Schneider, J., Kaaden, O., Copeland, T. D., Oroszlan, S., and Hunsmann, G., 1986, Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of human immunodeficiency virus, J. Gen. Virol. 67:2533.
Schnittman, S. M., Greenhouse, J. J., Psallidopoulos, M. C., Baseler, M., Salzman, N. P., Fauci, A. S., and Lane, H. C., 1989, The reservoir for HIV-1 in human peripheral blood is a T-cell that maintains expression of CD4, Science 245:305.
Schrier, R. D., Gnann, Jr., J. W., Langlois, A. J., Shriver, K., Nelson, J. A., and Oldstone, M. B. A., 1988, B-and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus, J. Virol. 62:2531.
Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, E. M., and Pavlakis, G. N., 1990, Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1, J. Virol. 64:2519.
Sellon, D. C., Perry, S. T., Coggins, L., and Fuller, F. J., 1992, Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes, J. Virol. 66:5906.
Sentsui, H., and Kono, Y., 1976, Hemagglutination by equine infectious anemia virus, Infect. Immun. 14:325.
Sentsui, H., and Kono, Y., 1981, Hemagglutination-inhibition tests with different strains of equine infectious anemia virus, Am. J. Vet. Res. 42:1949.
Sentsui, H., and Kono, Y., 1987a. Complement-mediated hemolysis of erythrocytes treated with equine infectious anemia virus, Arch. Virol. 95:53.
Sentsui, H., and Kono, Y., 1987b. Phagocytosis of horse erythrocytes treated with equine infectious anemia virus by cultivated horse leukocytes, Arch. Virol. 95:67.
Sentsui, H., and Kono, 1988, Studies on viral-induced anemia in horses infected with EIAV, Jpn. J. Vet. Sci. 50:303.
Shane, B. S., Issel, C. J., and Montelaro, R. C., 1984, Enzyme-linked immunosorbent assay for the detection of equine infectious anemia virus p26 antigen and antibody, J. CJin. Microbiol. 19:351.
Sharpee, R., Beckenhauer, W., Baumgartener, L., Haffer, K., and Olsen, R., 1986, Feline leukemia vaccine: Evaluation of safety and efficacy against persistent viremia and tumor development, Compend. Contin. Educ. Pract. Vet. 8:267.
Shen, R., and Wang, Z., 1985, Development and use of an equine infectious anemia donkey leucocyte attenuated vaccine, in: Equine Infectious Anemia: A National Review of Policies, Programs, and Future Objectives (R. Tashjian, ed.), pp. 135–248, American Quarter Horse Association, Amarillo, TX.
Sherman, L., Gazit, A., Yaniv, A., Kawakami, T., Dahlberg, J. E., and Tronick, S. R., 1988, Localization of sequences responsible for trans-activation of the equine infectious anemia virus long terminal repeat, J. Virol. 62:120.
Sherman, L., Yaniv, A., Lichtman-Pleban, H., Tronick, S. R., and Gazit, A., 1989, Analysis of regulatory elements of the equine infectious anemia virus and caprine arthritis-encephalitis virus long terminal repeats, J. Virol. 63:4925.
Shih, A., Misra, R., and Rush, M. G., 1989, Detection of novel reverse transcriptase coding sequences in human nucleic acids: Relation to primate retroviruses, J. Virol. 63:64.
Simmonds, P., Balfe, P., Ludlam, C. A., Bishop, J. O., and Brown, A. J. L., 1990, Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1, J. Virol. 64:5840.
Skehel, J. J., Bayley, P. M., Broun, E. B., Martin, S. R., Waterfield, M. D., White, J. M., Wilson, I. A., and Wiley, D. C., 1982, Changes in the conformation of influenza hemagglutinin at the pH optimum of virus-mediated membrane fusion, Proc. Natl. Acad. Sci. USA 79:968.
Slosberg, B. N., and Montelaro, R. C., 1982, A comparison of the mobilities of retrovirus envelopes and host cell membranes by electron spin resonance spectroscopy. Biochem. Biophys. Acta. 689:393.
Sonigo, P., Alozon, M., Staskus, K., Klatzmann, D., Cole, S., Danos, O., Retzel, E., Tiollais, P., Haase, A., and Wain-Hobson, A., 1985, Nucleotide sequence of the visna lentivirus: Relationship to the AIDS virus. Cell 42:369.
Spouge, J. L., Guy, H. R., Cornette, J. L., Margalit, H., Cease, K., Berzofsky, J. A., and Delisi, C., 1987, Strong conformational propensities enhance T cell antigenicity, J. Immunol. 138:204.
Staskus, K. A., Retzel, E. F., Lewis, E. K., Silsby, J. L., St. Cyr, S., Rank, J. M., Wietgrefe, S. W., Haase, A. T., Cook, R., Fast, D., Geiser, P. T., Harty, J. Y., Kong, S. H., Lahti, C. J., Neufeld, T. P., Porter, T. E., Shoop, E., and Zachow, K. R., 1991, Isolation of replication-competent molecular clones of visna virus, Virology 181:228.
Stein, C. D., and Osteen, O. L., 1941, Studies on immunization in equine infectious anemia, Am. J. Vet. Res. 2:344.
Stephens, R. M., Casey, J. W., and Rice, N. R., 1986, Equine infectious anemia virus gag and pol genes: Relatedness to visna and AIDS vaccine, Science 231:589.
Stephens, R. M., Derse, D., and Rice, N. R., 1990, Cloning and characterization of cDNAs encoding equine infectious anemia virus tat and putative rev proteins, J. Virol. 64:3716.
Stowring, L., Haase, A. T., and Charman, H. P., 1979, Serological definition of the lentivirus group of retroviruses, J. Virol. 29:523.
Strebel, K., Klimkait, T., Maldarelli, F., and Martin, M. A., 1989, Molecular and biochemical analyses of human immunodeficiency type 1 vpu protein, J. Virol. 63:3784.
Strieker, R. B., Abrams, D. I., Corash, L., and Shuman, M. A., 1985, Target platelet antigen in homosexual men with immune thrombocytopenia, N. Engl. J. Med. 313:1375.
Swardson, C. J., Kociba, G. J., and Perryman, L. E., 1992, Effects of equine infectious anemia virus on hematopoietic progenitors in vitro, Am. J. Vet. Res. 53:1176.
Tabuchi, E., Ishil, S., and Sonoda, A., 1957, Studies on the immunity of equine infectious anemia by the inoculation of larger volumes of formalized viruses, Exp. Rep. Equine Infect. Anemia. (Hokkaido Pref. Gov.), 2:71.
Tajima, M., and Yamagiwa, S., 1953a, Histopathological studies on the central nervous system in equine infectious anemia. I: Description of the pathological changes in representative cases, Jpn. J. Vet. Sci. 15:37.
Tajima, M., and Yamagiwa, S., 1953b, Histopathological studies on the central nervous system in equine infectious anemia. II: Summarized description of the pathological changes in the total cases studied, Jpn. J. Vet. Sci. 15:49.
Takahashi, H., Cohen, J., Hosmailing, A., Cease, K. B., Houghten, R., Cornette, J. L., Delisi, C., Moss, B., Germain, R. N., and Berzofsky, J. A., 1988, An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes, Proc. Natl. Acad. Sci. USA 85:3105.
Takeda, A., Tuazon, C. U., and Ennis, F. A., 1988, Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry, Science 242:580.
Takeuchi, Y., Nagumo, T., and Hoshino, H., 1988, Low fidelity of cell-free DNA synthesis by reverse transcriptase of human immunodeficiency virus, J. Virol. 62:3900.
Telen, M. J., Roberts, K. B., and Bartlett, J. A., 1990, HIV-associated autoimmune hemolytic anemia: Report of a case and review of the literature, J. Acq. Immun. Def. Syn. 3:933.
Tersmette, M., deGoede, R. E. Y., AI, B. J. M., Winkel, I. N., Gruters, R. A., Cuypers, H. T., Huisman, H. G., and Miedma, F., 1988, Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncitium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, J. Virol. 62:2026.
Thomas, D. A., and Furman, P. A., 1991, Purification and characterization of equine infectious anemia virus reverse transcriptase, Biochem. Biophys. Res. Commun. 180:1365.
Tiley, L. S., Brown, P. H., Le, S. Y., Maizel, J. V., Clements, J. E., and Cullen, B. R., 1990, Visna virus encodes a post-transcriptional regulator of viral structural gene expression, Proc. Natl. Acad.Sci. USA 87:7497.
Tong-Starksen, S., and Peterlin, B. M., 1990, Mechanism of retroviral transcriptional activation, in: Seminars in Virology: Advances in Retrovirology (Irvin S. Y. Chin, ed.), Vol. 1, pp. 215–228, W. B. Saunders, Philadelphia.
Vallee, H., and Carree, H., 1904. Sur la natur infectieuse de l’anemie du cheval, Compt. Rend. Acad. Sci. 139:1239.
Vartanian, J. P., Meyerhans, A., Asjo, B., and Wain-Hobson, S., 1991, Selection, recombination and G → A hypermutation of human immunodeficiency virus type 1 genomes, J. Virol. 65:1779.
Venable, R. M., Pastor, R. W., Brooks, B. R., and Carson, F. W., 1989, Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein, AIDS Res. Hum. Retroviruses 5:7.
Vigne, R., Barban, V., Querat, G., Mazarin, I., Gourdon, I., and Sauze, N., 1987, Transcription of visna virus during its lytic cycle: Evidence for a sequential early and late gene expression, Virology 161:218.
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., and Alizon, M., 1985, Nucleotide sequence of the AIDS virus, LAV, Cell 40:9.
Walsh, C. M., Nardi, M. A., and Karpatkin, S., 1984, On the mechanism of thrombocytopenic purpura in sexually active homosexual men, N. Engl. J. Med. 311:356.
Wang, J. J. G., Steel, S., Wisniewolski, R., and Wang, C. Y., 1986, Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein, Proc. Natl. Acad. Sci. USA 83:6159.
Weber, J., and Grosse, F., 1989, Fidelity of human immunodeficiency virus type 1 reverse transcriptase in copying natural DNA, Nucleic Acids Res. 17:1379.
Whetter, L., Archambault, D., Perry, S., Gazit, A., Coggins, L., Yaniv, A., Clabough, D., Dahlberg, J., Fuller, J., and Tronick, S. R., 1990, Equine infectious anemia virus derived from a molecular clone persistently infects horses, J. Virol. 64:5750.
Williams, D. L., Issel, C. J., Steelman, C. D., Adams, W. V., and Benton, C. V., 1981, Studies with equine infectious anemia virus: transmission attempts by mosquitoes and survival of virus on vector mouthparts and hypodermic needles, and in mosquito tissue culture, Am. J. Vet. Res. 42:1469.
Williams, K. J., Loeb, L. A., and Fry, M., 1990, Synthesis of human immunodeficiency virus reverse transcriptase is preferentially blocked at template oligo(dA) tracts, J. Biol. Chem. 265:18682.
Wilson, I. A., Skehel, J. J., and Wiley, D. C., 1981, Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution, Nature 289:366.
Wilson, W., Braddock, M., Adams, S. E., Rathjen, P. D., Kingsman, S. M., and Kingsman, A. J., 1988, HIV expression strategies: Ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems, Cell 55:1159.
Windheuser, M. G., Tegtmeier, G. E., and Wood, C., 1989, Use of TrpE-gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein, J. Virol. 63:4064.
Winston, S., Fiscus, S., Hesterberg, L., Matsushita, T., Mildbrand, M., Porter, J., and Teramoto, Y., 1987, Rapid detection of viral specific antibodies by enzyme-linked immunosorbent assay (ELISA), Vet. Immunol. Immunopathol. 17:1.
Wong-Staal, F., 1990, Human immunodeficiency viruses and their replication, in: Virology (2d ed.) pp. 1529–1543, Raven Press, New York.
Wraith, D. C., Vessey, A. E., and Askonas, B. A., 1987, Purified influenza virus nucleoprotein protects mice from lethal infection, J. Gen. Virol. 68:433.
Wu, F., Garcia, J., Mitsuyasu, R., and Gaynor, R., 1988, Alterations in binding characteristics of the human immunodeficiency virus enhancer factor, J. Virol. 62:218.
Yamamoto, J. K., Hohdatsu, T., Olmsted, R. A., Pu, R., Louie, H., Zochlinski, H. A., Acevedo, V., Johnson, H. M., Soulds, G. A., and Gardner, M. B. 1993. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 67:601–605.
Yaniv, A., Dahlberg, J., Gazit, A., Sherman, L., Chiu, I. M., Tronick, S. R., and Aaronson, S. A., 1986, Molecular cloning and physical characterization of integrated equine infectious anemia virus: Molecular and immunologic evidence of its close relationship to ovine and caprine lentiviruses, Virology 154:1.
Yaniv, A., Sherman, L., Noiman, S., Tori, O., Lichtman-Pleban, H., Miki, T., Tronick, S. R., and Gazit, A., 1989, Studies on the regulation and patterns of expression of the equine infectious anemia virus genome, in: Developments in Biological Standardization: Progress in Animal Retroviruses (D. Gaudry and W. Hennessen, eds.), Vol. 72, pp. 59–73, S. Karger, Basel.
Zasloff, M., Bartin, B., and Chen, H. C., 1988, Antimicrobial activity of synthetic magainin peptides and several analogues, Proc. Natl. Acad. Sci. USA 85:910.
Zucker, M., and Stiegler, P., 1981, Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information, Nucleic Acids Res. 9:133.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Montelaro, R.C., Ball, J.M., Rushlow, K.E. (1993). Equine Retroviruses. In: Levy, J.A. (eds) The Retroviridae. The Viruses. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1627-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1627-3_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1629-7
Online ISBN: 978-1-4899-1627-3
eBook Packages: Springer Book Archive